Valuation West Pharmaceutical Services, Inc. Sao Paulo
Stocks
W2ST34
BRW2STBDR007
Medical Equipment, Supplies & Distribution
|
Delayed
Sao Paulo
13:53:32 2026-09-08 EDT
|
5-day change | 1st Jan Change | ||
| 49.25 BRL | -2.36% |
|
-.--% | +20.83% |
| 08:25am | Barclays Raises West Pharmaceutical Services Price Target to $440 From $400, Maintains Overweight Rating | MT |
| 09-23 | US companies face rise in cyber attacks | RE |
Company Valuation: West Pharmaceutical Services, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 34,744 | 17,424 | 26,053 | 23,723 | 19,795 | 26,515 | - | - |
| Change | - | -49.85% | 49.53% | -8.95% | -16.56% | 33.95% | - | - |
| Enterprise Value (EV) 1 | 34,744 | 16,738 | 25,406 | 23,441 | 19,206 | 26,012 | 25,541 | 25,173 |
| Change | - | -51.82% | 51.78% | -7.74% | -18.07% | 35.43% | -1.81% | -1.44% |
| P/E | 54.1x | 30.4x | 44.7x | 49x | 40.5x | 43.9x | 38.2x | 34.1x |
| PBR | 14.9x | 6.5x | 8.98x | 8.83x | 5.95x | 8.39x | 7.4x | 6.59x |
| PEG | - | -2.8x | 23.04x | -3.2x | 27.09x | 1.7x | 2.5x | 2.9x |
| Capitalization / Revenue | 12.3x | 6.04x | 8.83x | 8.2x | 6.44x | 7.86x | 7.39x | 6.87x |
| EV / Revenue | 12.3x | 5.8x | 8.61x | 8.1x | 6.25x | 7.71x | 7.12x | 6.52x |
| EV / EBITDA | 39.3x | 19x | 30.7x | 32.2x | 24.2x | 27.7x | 24.6x | 21.7x |
| EV / EBIT | 45.6x | 22x | 36.8x | 40.9x | 30.9x | 34.4x | 30.1x | 26.3x |
| EV / FCF | 105x | 38.1x | 61.3x | 84.8x | 41x | 60.4x | 45x | 34.7x |
| FCF Yield | 0.95% | 2.63% | 1.63% | 1.18% | 2.44% | 1.66% | 2.22% | 2.88% |
| Dividend per Share 2 | 0.69 | 0.74 | 0.78 | 0.82 | 0.85 | 0.9025 | 0.9729 | 1.118 |
| Rate of return | 0.15% | 0.31% | 0.22% | 0.25% | 0.31% | 0.24% | 0.26% | 0.3% |
| EPS 2 | 8.67 | 7.73 | 7.88 | 6.69 | 6.79 | 8.575 | 9.865 | 11.04 |
| Distribution rate | 7.96% | 9.57% | 9.9% | 12.3% | 12.5% | 10.5% | 9.86% | 10.1% |
| Net sales 1 | 2,832 | 2,887 | 2,950 | 2,893 | 3,074 | 3,375 | 3,587 | 3,860 |
| EBITDA 1 | 884.7 | 882.6 | 827.9 | 728.2 | 793.8 | 939.3 | 1,040 | 1,159 |
| EBIT 1 | 762.4 | 762 | 690.6 | 572.8 | 622.4 | 757.1 | 848.8 | 957 |
| Net income 1 | 661.8 | 585.9 | 593.4 | 492.7 | 493.7 | 621.5 | 710.2 | 798.6 |
| Net Debt 1 | - | -685.4 | -647.1 | -282 | -588.5 | -503.3 | -973.5 | -1,342 |
| Reference price 2 | 469.01 | 235.35 | 352.12 | 327.56 | 275.14 | 376.76 | 376.76 | 376.76 |
| Nbr of stocks (in thousands) | 74,080 | 74,033 | 73,990 | 72,422 | 71,943 | 70,376 | - | - |
| Announcement Date | 2/17/22 | 2/16/23 | 2/15/24 | 2/13/25 | 2/12/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 29.3x | 3.93x | 15.19x | 2.57% | 173B | ||
| 18.81x | 3.43x | 12.27x | 3.2% | 113B | ||
| 22.18x | 4.35x | 15.2x | 1.26% | 109B | ||
| 25.57x | 2.52x | 10.12x | 2.8% | 74.44B | ||
| 17.25x | 0.2x | 12.62x | 0.75% | 60.1B | ||
| 30x | 7.4x | 19.18x | 1.33% | 51.87B | ||
| 34.82x | 3.38x | 11.57x | 2.17% | 49.21B | ||
| 35.69x | 8.87x | 24.95x | -.--% | 41.52B | ||
| 34.92x | 6.12x | 19.22x | -.--% | 32.79B | ||
| Average | 27.61x | 4.47x | 15.59x | 1.57% | 78.34B | |
| Weighted average by Cap. | 26.17x | 4.06x | 14.77x | 1.95% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- WST Stock
- W2ST34 Stock
- Valuation West Pharmaceutical Services, Inc.
Select your edition
All financial news and data tailored to specific country editions
















